Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.

A CRISPR-based gene therapy showed improvement in lipids in difficult-to-treat patients, but one study raised flags after a death last month in a trial of an unrelated gene therapy.

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol ...

In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...